WebFood and Drug Administration WebMar 25, 2024 · The GenMark Dx ePlex Blood Culture Identification Gram-Positive (BCID-GP) Panel is a multiplex nucleic acid amplification assay based on competitive DNA hybridization and electrochemical detection using eSensor technology.
Respiratory Pathogen Panels GenMark Diagnostics
WebExplore the ePlex ® BCID Panels benefits Early identification helps improve patient outcomes It is estimated that 20-30% of patients receive ineffective initial antibiotic therapy and the mortality rate for these patients increases up to 7.6% for every hour effective antibiotics are delayed. 3,4 The ePlex ® BCID Panels aid you in the identification of … Web1 The ePlex Respiratory Pathogen Panel 2 (EPlex RP2 Panel) is intended for the detection and differentiation of ... Respiratory Pathogen Panel 2 Package Insert” Instructions for Use (available ... rcw prescription forgery
ePlex Respiratory Pathogen Panel PI1056 REV. A
WebePlex ® Panels. Infectious diseases, such as lower respiratory infections, bloodstream infections that can lead to sepsis, and diarrhea are among the top causes of death … WebThese specimen types are specified in product package inserts cleared by the U.S. Food and Drug Administration (FDA) Test Time is inclusive of actual test time and is exclusive of transport, handling, laboratory run schedules, and generating results. Timing may vary depending on extraction process used. WebProduct Name: ePlex Blood Culture Identification Fungal Pathogen (BCID-FP) Panel Device Classification: 866.3980, Multiplex nucleic acid assay for identification of microorganisms … rcwpps